Instant-View Benzodiazepine Drug Test
As Low As .81 each
The Benzodiazepine Rapid Drug Test Cassette (case of 25) is CLIA Waived & FDA 510K #K063545, simply dip the card in urine and read results in 4 minutes. - The Instant-View® Benzodiazepine urine drug test is a one-step, lateral flow test designed to qualitatively identify benzodiazepine abuse by detecting oxazepam in human urine at a cut-off level of 300 ng/ml. Benzodiazepines are sedative, hypnotic and anti-anxiety drugs commonly used as tranquilizers. Most members of the Benzodiazepine family are detectable for 1-2 days; Oxazepam, a common metabolite of many benzodiazepines, may remain detectable in urine for up to one week. Therefore, oxazepam is a useful marker of benzodiazepine abuse. The Instant-View® Benzodiazepine urine drug test provides qualitative screening results and is for use by healthcare professionals only. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. The test is available in cassette and dip strip formats, with the option of being included in the Instant-View® multi-drug screen test.
Benzodiazepine urine cassette and dip strip test
Method
Lateral flow test
Cut-off level
300 ng/ml
Accuracy
99%
Precision
> 99%
Sample
Urine
Read time
4-7 minutes
Storage
Room temperature
Shelf life
24 months from date of manufacture
CLIA Classification
Waived
Feature
Benefit
Easy, one-step procedure
Fast results; minimizes user error
24-month shelf life at room temp. (from date of manufacture)
No special storage requirements to maintain stability
Small sample volume required
Tests can be reliably performed with minimal amount of specimen
Available in cassette or dip strip format
Various formats for applying specimen
300 ng/ml cut-off level
Meets SAMHSA standards for substance abuse screening
Assigned CPT Codes
Multiple Classes: 80100QW / G0430
Single Class: 80101QW / G0431
Accepted by Medicare for reimbursement
Made in U.S.A.
Consistent, on-time supply & ready technical support
-Catalog #: 03-3132
-Quantity: 25 Tests
FDA 510K & CLIA Waived
CPT Code: G0431-QW - Drug screen, qualitative; single drug class method (eg, immunoassay, enzyme assay), each drug class - avg reimbursement $19.72
NOTE: Its is always the healthcare provider's responsibility to establish reimbursement amount.
